|
|
||||||||
Cardiology Unit, Department of Medicine, and Departments of Neurobiology and Anatomy, University of Rochester Medical Center, Rochester, New York 14642
Cardiac sympathetic nerve terminal dysfunction
plays an important role in the downregulation of myocardial
-adrenoceptors in heart failure. To determine whether chronic
angiotensin-converting enzyme (ACE) inhibition improved cardiac
sympathetic nerve terminal function and hence increased myocardial
-adrenergic responsiveness, we administered ACE inhibitors to dogs
with chronic right-sided heart failure (RHF) produced by tricuspid
avulsion and pulmonary artery constriction. The RHF animals exhibited
fluid retention, elevated right heart filling pressures, blunted
inotropic response to isoproterenol, and reduced
-adrenoceptor
density. These changes were accompanied by decreases in right
ventricular norepinephrine (NE) uptake and neuronal NE
histofluorescence and tyrosine hydroxylase immunoreactive profiles. ACE
inhibitors had no effect on the production of heart failure but greatly
reduced the attenuation of cardiac NE uptake, neuronal NE
histofluorescence, and tyrosine hydroxylase immunoreactive profiles.
ACE inhibition also improved the inotropic response to isoproterenol
and restored myocardial
-adrenoceptor density. The changes probably
are caused by reduction of cardiac NE release by ACE inhibition and may
contribute to the beneficial effects of ACE inhibitor therapy in
patients with chronic heart failure.
congestive heart failure; sympathetic nerves; angiotensin-converting enzyme inhibition; tyrosine hydroxylase; norepinephrine
This article has been cited by other articles:
![]() |
W. Raasch, T. Bartels, A. Gieselberg, A. Dendorfer, and P. Dominiak Angiotensin I-Converting Enzyme Inhibition Increases Cardiac Catecholamine Content and Reduces Monoamine Oxidase Activity via an Angiotensin Type 1 Receptor-Mediated Mechanism J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 428 - 434. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kawai, S. Y. Stevens, and C.-S. Liang Renin-angiotensin system inhibition on noradrenergic nerve terminal function in pacing-induced heart failure Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H3012 - H3019. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Kaye, G. Vaddadi, S. L. Gruskin, X.-J. Du, and M. D. Esler Reduced Myocardial Nerve Growth Factor Expression in Human and Experimental Heart Failure Circ. Res., April 14, 2000; 86 (7): e80 - e84. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Qin, R. S. Vulapalli, S. Y. Stevens, and C.-S. Liang Loss of cardiac sympathetic neurotransmitters in heart failure and NE infusion is associated with reduced NGF Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H363 - H371. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |